Free Trial

UBS Group Has Lowered Expectations for W.R. Berkley (NYSE:WRB) Stock Price

W.R. Berkley logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • UBS Group cut its price target on W.R. Berkley from $71 to $69 and maintained a neutral rating, implying only about a 2.75% upside from the prior close.
  • Several other brokers have trimmed targets too, leaving the consensus Street rating at Hold with an average target of roughly $68.94.
  • Major shareholder Sumitomo Insurance bought 370,000 shares (~$24.8M), increasing its stake — a notable insider purchase amid the muted analyst outlook.
  • Five stocks to consider instead of W.R. Berkley.

W.R. Berkley (NYSE:WRB - Get Free Report) had its target price dropped by equities researchers at UBS Group from $71.00 to $69.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a "neutral" rating on the insurance provider's stock. UBS Group's target price would suggest a potential upside of 2.75% from the stock's previous close.

Other equities research analysts have also recently issued research reports about the stock. Mizuho cut their price objective on shares of W.R. Berkley from $69.00 to $67.00 and set a "neutral" rating for the company in a research report on Tuesday, January 27th. Keefe, Bruyette & Woods cut their price objective on shares of W.R. Berkley from $74.00 to $66.00 and set a "market perform" rating for the company in a research report on Wednesday, April 1st. Barclays cut their price objective on shares of W.R. Berkley from $64.00 to $62.00 and set an "underweight" rating for the company in a research report on Wednesday. TD Cowen cut shares of W.R. Berkley from a "buy" rating to a "sell" rating and cut their price objective for the stock from $77.00 to $55.00 in a research report on Tuesday, January 20th. Finally, Morgan Stanley cut their price objective on shares of W.R. Berkley from $73.00 to $72.00 and set an "equal weight" rating for the company in a research report on Monday. Four research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $68.94.

Get Our Latest Stock Report on WRB

W.R. Berkley Stock Performance

Shares of W.R. Berkley stock traded up $0.47 during trading on Wednesday, reaching $67.15. The company's stock had a trading volume of 1,713,416 shares, compared to its average volume of 2,283,095. W.R. Berkley has a 52 week low of $63.65 and a 52 week high of $78.96. The business's 50-day moving average price is $68.74 and its 200-day moving average price is $71.33. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.29. The firm has a market cap of $25.15 billion, a PE ratio of 15.09, a P/E/G ratio of 2.58 and a beta of 0.37.

W.R. Berkley (NYSE:WRB - Get Free Report) last posted its quarterly earnings data on Monday, January 26th. The insurance provider reported $1.13 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.01). W.R. Berkley had a return on equity of 18.17% and a net margin of 12.10%.The firm had revenue of $3.18 billion for the quarter, compared to the consensus estimate of $3.18 billion. During the same period in the prior year, the company earned $1.13 EPS. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. Equities analysts forecast that W.R. Berkley will post 4.33 earnings per share for the current year.

Insider Activity

In other news, major shareholder Sumitomo Insurance Co L. Mitsui acquired 370,000 shares of the stock in a transaction dated Monday, January 26th. The stock was bought at an average price of $67.07 per share, with a total value of $24,815,900.00. Following the completion of the purchase, the insider directly owned 54,959,504 shares of the company's stock, valued at $3,686,133,933.28. This represents a 0.68% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders purchased a total of 7,294,987 shares of company stock valued at $503,481,336 over the last three months. Corporate insiders own 23.00% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Entrust Financial LLC acquired a new position in shares of W.R. Berkley in the fourth quarter valued at approximately $25,000. Compass Financial Services Inc acquired a new position in shares of W.R. Berkley in the third quarter valued at approximately $26,000. Hazlett Burt & Watson Inc. increased its stake in shares of W.R. Berkley by 140.0% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 360 shares of the insurance provider's stock valued at $26,000 after buying an additional 210 shares during the period. DV Equities LLC acquired a new position in shares of W.R. Berkley in the fourth quarter valued at approximately $29,000. Finally, Triumph Capital Management acquired a new position in shares of W.R. Berkley in the third quarter valued at approximately $35,000. Institutional investors and hedge funds own 68.82% of the company's stock.

More W.R. Berkley News

Here are the key news stories impacting W.R. Berkley this week:

  • Positive Sentiment: Zacks Research issued multiple small upward revisions to WRB's earnings outlook — including modest raises to FY2026 and FY2028 estimates and several quarterly EPS tweaks — implying slightly stronger near‑term earnings visibility. These upgrades can be supportive for the share price if results continue to track above prior guidance. Zacks / MarketBeat summary
  • Neutral Sentiment: A Seeking Alpha piece highlights W.R. Berkley’s outstanding baby bonds as an attractively priced, investment‑grade income option. This could draw income‑oriented investors but is unlikely by itself to drive large moves in the equity. Seeking Alpha article
  • Neutral Sentiment: A roundup in The Globe and Mail notes conflicting analyst sentiment on WRB (some firms bullish, others bearish), underscoring the mixed messages investors are weighing. Globe and Mail article
  • Negative Sentiment: Barclays lowered its price target on W.R. Berkley from $64 to $62 and moved to an "underweight" rating — a direct negative for sentiment because the new PT implies roughly an ~7–8% downside versus current levels and may trigger selling or reduced buy interest. Benzinga coverage
  • Negative Sentiment: Morgan Stanley published a pessimistic forecast for WRB's stock, adding further bearish analyst pressure that could cap upside until clarity on underwriting outcomes or investment returns improves. American Banking News

W.R. Berkley Company Profile

(Get Free Report)

W. R. Berkley Corporation NYSE: WRB is a publicly traded insurance holding company that underwrites and sells commercial property and casualty insurance, specialty insurance products, and reinsurance. Headquartered in Greenwich, Connecticut, the company operates a portfolio of underwriting businesses that focus on niche and specialty commercial risks, offering coverage tailored to industries such as transportation, construction, professional services and other commercial lines.

The company's product mix includes primary and excess casualty, property, professional liability, environmental and other specialty lines, together with treaty and facultative reinsurance solutions.

See Also

Analyst Recommendations for W.R. Berkley (NYSE:WRB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in W.R. Berkley Right Now?

Before you consider W.R. Berkley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and W.R. Berkley wasn't on the list.

While W.R. Berkley currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines